Identification of two novel mutations and long-term follow-up in abetalipoproteinemia: a report of four cases
- 9 December 2008
- journal article
- case report
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 168 (8) , 983-989
Abstract
Abetalipoproteinemia (ABL; OMIM 200100) is an inherited disorder resulting from mutations in the microsomal triglyceride transfer protein gene and characterized by a major lipid malabsorption leading to extremely low plasma cholesterol and triglyceride levels and fat-soluble vitamins deficiencies. We report two novel mutations (c.59del17 and c.582C>A) and the long-term follow-up of four ABL subjects treated with vitamin E. The good outcome of the early-treated patients contrasts with severe ataxia and retinopathy observed in the patient with delayed treatment. In conclusion, early diagnosis and early management are essential to prevent the manifestations following the fat-soluble vitamin deficiencies.Keywords
This publication has 20 references indexed in Scilit:
- Abetalipoproteinemia: two case reports and literature reviewOrphanet Journal of Rare Diseases, 2008
- Novel mutations in abetalipoproteinaemia and homozygous familial hypobetalipoproteinaemiaJournal of Inherited Metabolic Disease, 2007
- Assessment of Tocopherol Metabolism and Oxidative Stress in Familial HypobetalipoproteinemiaClinical Chemistry, 2006
- An atypical case of abetalipoproteinaemia with severe fatty liver in the absence of steatorrhoea or acanthocytosisEuropean Journal of Pediatrics, 2005
- Lipid Disorders and Mutations in the APOB GeneClinical Chemistry, 2004
- Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipo-proteinaemia patientsEye, 2001
- The molecular basis of abetalipoproteinemiaCurrent Opinion in Lipidology, 1994
- Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemiaNature, 1993
- Absence of Microsomal Triglyceride Transfer Protein in Individuals with AbetalipoproteinemiaScience, 1992
- The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorptionJournal of Inherited Metabolic Disease, 1985